Rankings
▼
Calendar
MESO Q3 2020 Earnings — Mesoblast Limited Revenue & Financial Results | Market Cap Arena
MESO
Mesoblast Limited
$2B
Q3 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$12M
+867.3% YoY
Gross Profit
-$10M
-82.0% margin
Operating Income
-$16M
-128.5% margin
Net Income
-$15M
-126.3% margin
EPS (Diluted)
$-0.28
QoQ Revenue Growth
+513.6%
Cash Flow
Operating Cash Flow
-$20M
Free Cash Flow
-$21M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$666M
Total Liabilities
$178M
Stockholders' Equity
$488M
Cash & Equivalents
$60M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$12M
$1M
+867.3%
Gross Profit
-$10M
-$2M
-409.8%
Operating Income
-$16M
-$22M
+28.4%
Net Income
-$15M
-$25M
+38.9%
← FY 2020
All Quarters
Q4 2020 →